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Abstract 
Veterinary vaccines have had, and continue to have, a major role in protecting animal health and public health, reducing animal 
suffering, enabling efficient production of food animals to feed the burgeoning human population, and greatly reducing the need 
for antibiotics to treat food and companion animals. Prominent examples include rabies vaccines and rinderpest vaccines. Rabies 
vaccines for domestic animals and wildlife have nearly eliminated human rabies in developed countries. Thanks to the Global 
Rinderpest Eradication Program which involves vaccination, trade restrictions, and surveillance, rinderpest may soon become 
only the second disease (after smallpox) to be globally eradicated. Successful examples of new technology animal vaccines that 
are licensed for use, include gene-deleted marker vaccines, virus-like-particle vaccines, recombinant modified live virus 
vaccines, chimeric vaccines, and DNA vaccines. Animal vaccines also use a wide variety of novel adjuvants that are not yet 
approved for use in human vaccines. Animal vaccines can be developed and licensed much more quickly than human vaccines. 
The West Nile virus was discovered in the United States in August 1999. By August 2001, an Equine vaccine for West Nile virus 
was conditionally licensed. For animal vaccines to effectively protect animal and public health they must be widely used, which 
means they must be affordable. The regulatory process must meet the need for assuring safety and efficacy without increasing the 
cost of licensing and production to the point where they are not affordable to the end user. 
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1. Introduction 
Veterinary vaccines are important for animal health, animal welfare, food production, and public health. They are 
a cost-effective method to prevent animal disease, enhance the efficiency of food production, and reduce or prevent 
transmission of zoonotic and foodborne infections to people. Safe and effective animal vaccines are essential to 
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modern society. It would be impossible to produce enough animal protein to feed the nearly 7 billion people on earth 
without vaccines to prevent epizootics in food-producing animals. Without companion animal vaccines (especially 
rabies vaccine), many people would not keep a pet in the household and would not experience the satisfaction of the 
human animal bond. Zoonotic diseases such as brucellosis and leptospirosis would be much more prevalent without 
effective vaccines. The impact of veterinary vaccines can be seen in the following examples. 
Rinderpest is an example of how a disease that only affects animals can have a large public health impact. 
Rinderpest is an acute, highly contagious, viral disease of cattle, domesticated buffalo, and some species of wildlife. 
In 1889, cattle shipped from India carried the rinderpest virus to Africa, causing an epidemic that established the 
virus on the continent. Initially, approximately 90% of the cattle in sub-Saharan Africa died as well as many sheep 
and goats. Wild buffalo, giraffe, and wildebeest populations were decimated. The loss of draft animals, domestic 
livestock, and wildlife resulted in mass starvation, killing a third of the human population in Ethiopia and two-thirds 
of the Maasai people of Tanzania. The reduced number of grazing animals allowed thickets to form in grasslands. 
These thickets served as breeding grounds for tsetse flies, the vector for trypanosomes, resulting in an outbreak of 
trypanosomiasis (African sleeping sickness) in humans. This rinderpest epidemic is considered by some to have 
been the most catastrophic natural disaster ever to affect Africa. The Global Rinderpest Eradication Program is a 
large-scale international collaboration involving vaccination, local and international trade restrictions, and 
surveillance. This effort may be one of veterinary medicine’s greatest achievements and rinderpest may soon 
become only the second disease (after smallpox) to be globally eradicated [1]. 
The rabies vaccine is another example of the impact of a successful animal vaccine. Rabies may be the oldest 
infectious disease known to man. Rabies vaccines for domestic animals and wildlife have nearly eliminated human 
rabies in developed countries. However, more than 55,000 people die of rabies every year in Asia and Africa and 
98% of those cases are due to people being bitten by dogs that are not vaccinated [2]. This source of rabies in 
humans can be eliminated by adequate animal vaccination and control, educating those at risk, and enhancing access 
to appropriate medical care for those who are bitten. Affordability and availability of rabies vaccines, along with 
effective vaccination programs are key to changing the current situation. 
2. Importance of veterinary vaccines 
2.1. Safe and efficient food production  
Veterinary vaccines are used in livestock and poultry to maintain animal health and to improve overall 
production. More efficient animal production and better access to high-quality protein are essential to feed the 
growing population. According to the United Nations Department of Economic and Social Affairs Population 
Division, the world population was approximately 6.9 billion in 2010, and is estimated to increase to just over 8 
billion in 2025 and to reach 9.1 billion people in 2050 (Figure 1). The United Nations Food and Agriculture 
Organization (FAO) estimates that 1.02 billion people were undernourished in 2009, in both developed and 
developing countries (Figure 2). There have been dramatic increases in world meat and egg production between 
1961 and 2007 (Figure 3). An FAO High-Level Expert Forum reported in September 2009 that in order to feed a 
projected world population of 9.1 billion people, the overall food production will need to increase by 70% between 
2005/07 to 2050 [3]. Vaccines that preserve animal health and improve production are important components in 
meeting this need.  
2.2. Control of zoonotic diseases 
Vaccines to control zoonotic diseases in food animals, companion animals, and even wildlife have had a major 
impact on reducing the incidence of zoonotic diseases in people (Table 1). Without rabies vaccines, it is unlikely 
that families would be willing to keep cats and dogs as pets. Recombinant vaccinia-vectored rabies vaccines have 
also been used successfully in baits for oral vaccination campaigns to reduce the incidence of rabies in wild animals 
[4] Vaccines for Brucellosis were instrumental in the Brucella abortus eradication program in the United States. 
Many countries have severe problems with Brucellosis in cattle, small ruminants, and people due to a lack of 
available Brucella vaccines for animals [5].  
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2.3. Control of emerging and exotic diseases of animals and people 
Emerging and exotic animal diseases are a growing threat to human and animal health and jeopardize food 
security (Figure 4). Increases in human and animal populations, with accompanying environmental degradation and 
globalized trade and travel, enhance opportunities for transfer of pathogens within and between species. The 
resulting diseases pose enormous challenges now and for the future. In most of the world, increased demand for 
animal protein has resulted in intensified commercial food animal production and/or expanded “backyard” 
 
Figure 1. Estimated population of the world from approximately the last 2000 years through 2050. (Reprinted with permission 
from: Roth, J. A., Galyon, J., Stumbaugh, A. Causes and Consequences of Emerging and Exotic Diseases of Animals: Role of the 
Veterinarian. In Emerging and Exotic Diseases of Animals, 4th Edition, 2010, Rovid-Spickler, A., Roth, J.A., Galyon, J., Lofstedt, J. 
Editors. Center for Food Security and Public Health, Ames, IA. USA.  
Figure 2. Estimated number and distribution of undernourished people in the world from 1970 through 2009. (Reprinted with 
permission from: Roth, J. A., Galyon, J., Stumbaugh, A. Causes and Consequences of Emerging and Exotic Diseases of Animals: 
Role of the Veterinarian. In Emerging and Exotic Diseases of Animals, 4th Edition, 2010, Rovid-Spickler, A., Roth, J.A., Galyon, J., 
Lofstedt, J. Editors. Center for Food Security and Public Health, Ames, IA. USA. 
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production. Both types of production present unique challenges for disease emergence and control. Emerging 
zoonotic diseases of both food and companion animals are a major threat to public health. It is inevitable that the 
world will continue to experience emerging disease outbreaks in the coming decades. Rapid development of animal 
vaccines can play a key role in controlling emerging diseases.  
 
 
 
 
 
2.4. Reduction of the need for antibiotics 
Veterinary vaccines reduce the need for antibiotics to treat infections in food producing and companion animals. 
There are increasing concerns related to antibiotic resistance associated with the extensive use of antibiotics in 
veterinary and human medicine [6]. Producers may choose either vaccines or antibiotics to control some diseases 
based on cost, if both options are available. For example, swine dysentery due to Lawsonia intracellularis can be 
controlled by either vaccination or antibiotics, along with good management practices. Swine producers will use the 
approved control method that is most cost effective. If regulatory requirements for a biologics company to obtain 
and maintain a license to produce the vaccine were to increase, then the cost of the vaccine would increase and 
producers would opt to use less vaccine and more antibiotics. Affordable and available vaccines reduce reliance on 
antibiotics for animal health.  
2.5. Food safety vaccines 
Recently, vaccines have been developed to reduce the shedding of organisms that cause food borne diseases in 
people. Vaccines for E coli O157:H7 in cattle and Salmonella enteritidis in chickens are available. These vaccines 
typically do not improve the health of the vaccinated animal, but they reduce the shedding of pathogens that may 
contaminate animal products for human consumption. The severity of the S. enteritidis outbreak in people in the 
United States in 2010 due to consumption of contaminated eggs could have been reduced or prevented if the 
chickens had received the S. enteritidis vaccine.  
Figure 3. Estimated world meat and egg production in 1961 and 2007. (Reprinted with permission from: Roth, J. A., Galyon, J., 
Stumbaugh, A. Causes and Consequences of Emerging and Exotic Diseases of Animals: Role of the Veterinarian. In Emerging and 
Exotic Diseases of Animals, 4th Edition, 2010, Rovid-Spickler, A., Roth, J.A., Galyon, J., Lofstedt, J. Editors. Center for Food 
Security and Public Health, Ames, IA. USA. 
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Table 1. Veterinary vaccines for the following zoonotic diseases have been, or could be, used to control 
infections in animals, thereby reducing transmission of the infectious agent to people 
Rabies 
Brucellosis 
Leptospirosis 
Influenza 
Rift Valley fever 
Nipah and Hendra 
Japanese encephalitis 
Q fever 
 
 
 
2.6. Control of diseases of companion animals and horses 
Vaccines for diseases of companion animals (Tables 2,3) and horses (Table 4) have greatly enhanced the ability 
to keep animals in the household and to own horses. The human-animal bond that develops enriches the lives of 
both the animals and the people. 
3. Diversity of veterinary vaccines 
Animal vaccines are developed and licensed for a variety of purposes. Most are used to prevent infectious 
diseases. Livestock vaccines are used for different purposes than human vaccines. Livestock vaccines are primarily 
used to improve the efficiency of production of food animals. The cost of the vaccine is an important consideration 
as to whether the vaccine will be used. It must contribute to profitability for the producer in the long run to be 
widely accepted. Companion animal vaccines are similar to human vaccines in that the health and welfare of the 
 
 
 
Figure 4. Emerging and re-emerging diseases affecting companion animal and food animal species. (Reprinted with permission from: Roth, 
J. A., Galyon, J., Stumbaugh, A. Causes and Consequences of Emerging and Exotic Diseases of Animals: Role of the Veterinarian. In Emerging 
and Exotic Diseases of Animals, 4th Edition, 2010, Rovid-Spickler, A., Roth, J.A., Galyon, J., Lofstedt, J. Editors. Center for Food Security and 
Public Health, Ames, IA. USA. 
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individual animal is often the primary consideration. Vaccination against zoonotic diseases and foodborne pathogens 
can be used to reduce or eliminate the risk to people. Wildlife vaccines are generally used for zoonotic diseases 
(e.g., oral bait vaccines for rabies), or in some cases in conjunction with disease control programs in domestic 
species (e.g., Brucellosis vaccine for bison and elk).  
 
Table 2. Canine vaccines licensed for use in the US by the USDA Center for Veterinary Biologics (AAHA 
Canine Vaccine Task Force (2003, 2006) 
http://www.aahanet.org/PublicDocuments/VaccineGuidelines06Revised.pdf) 
Canine Distemper virus 
Canine Parvovirus 
Canine adenovirus 2 
Rabies 
Canine parainfluenza 3 
Leptospira (5 serovars) 
Bordetella bronchiseptica 
Borrelia burgdorferii 
Canine distemper/measles 
Giardia spp. 
Canine corona virus 
Rattlesnake venom 
Periodontal disease 
 
Today in the United States, there are 1,958 veterinary biologic products that cover 213 different animal diseases. 
These products are manufactured in 161 different facilities and by 97 licensees or permittees [7]. Licensed animal 
vaccines are available for diseases where vaccines are not available for analogous human diseases, such as feline 
immunodeficiency virus, and feline leukemia virus. Other examples include a vaccine to protect dogs from 
rattlesnake venom, a vaccine for periodontal disease in dogs, and a nucleic acid-mediated vaccine for treatment of 
malignant melanoma in dogs [8]. 
 
Table 3. Feline vaccines licensed for use in the US by the USDA Center for Veterinary Biologics (The 2006 
AAFP Feline Vaccine Advisory Panel Report; Journal of the American Veterinary Medical 
Association 2006;229:1405-1441) 
Feline panleukopenia Virus 
Feline Viral Rhinotracheitis 
Feline Calicivirus 
Rabies 
Feline Immunodeficiency Virus 
Feline Leukemia Virus 
Bordetella bronchiseptica 
Chlamydophila felis 
Feline Infectious Peritonitis 
Giardia 
 
Veterinary vaccines have a distinct advantage in that they can be developed and licensed much more quickly and 
at much less cost than human vaccines. The ability to conduct safety and efficacy studies, including 
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vaccination/challenge studies in the target species greatly facilitates licensing of veterinary vaccines. Liability issues 
associated with adverse reactions for manufacturers of veterinary vaccines are much less than for manufacturers of 
human vaccines. 
 
Table 4. Equine vaccines licensed for use in the US by the USDA Center for Veterinary Biologics (AAEP 
Guidelines for the Vaccination of Horses (2008); http://www.aaep.org/vaccination_guidelines.htm) 
Tetanus 
Eastern and Western Equine Encephalomyelitis 
West Nile Virus 
Rabies 
Anthrax 
Botulism 
Equine Herpes Virus 
Equine Viral Arteritis 
Equine influenza 
Potomac horse fever 
Rotaviral diarrhea 
Strangles 
 
The equine West Nile virus vaccine is an example of how an animal vaccine can be developed and licensed 
quickly to meet an emergency situation. The West Nile virus was discovered in the United States in August 1999. 
The veterinary vaccine industry, working in cooperation with the USDA Center for Veterinary Biologics, quickly 
developed an effective vaccine to prevent the disease in horses. By August 2001, an equine vaccine for West Nile 
virus was conditionally licensed by the USDA. West Nile virus vaccine is now considered one of the core equine 
vaccines in the United States. [9]. The vaccine has also been used off label to protect some endangered birds, such 
as California condors. Porcine circovirus 2 vaccines and swine influenza pandemic H1N1 vaccines are additional 
examples of newly emerging diseases for which vaccines were developed and licensed quickly.  
A disadvantage of veterinary vaccines is that the potential financial returns are much less than for human 
vaccines. Veterinary vaccines have lower sales prices and smaller potential market value. Consequently, there is a 
lower investment in research and development for animal vaccines than human vaccines, although the range of hosts 
and pathogens are greater. 
4. Advances in vaccinology  
The science behind vaccines changed little until about 20 years ago when the first genetically engineered 
veterinary vaccines were developed and licensed. These vaccines were able to successfully control Aujeszky’s 
disease in pigs [10] and rabies in wildlife [11]. In the United States there are 15 licensed live vector vaccines 
(including chimeric vaccines), seven non-replicating recombinant antigen vaccines (including virus-like-particle 
vaccines, and vaccines derived from genetically engineered plants), four live-gene-deleted vaccines and two nucleic 
acid-mediated vaccines (Table 5) [8]. 
Another example of a novel vaccine that is currently licensed in other countries, but not the United States, is a 
vaccine that induces antibodies to gonadotropin releasing hormone to prevent the need to castrate male pigs. 
5. Vaccine needs 
The USDA and Department of Homeland Security have recognized the need to have licensed vaccines for 
important animal diseases that are not currently present in the United States. Since the diseases are not present in the 
United States, there is no market for the vaccines. Consequently, no biologics companies have gone to the expense 
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to license vaccines for those diseases. However, US animal agriculture is highly vulnerable to the introduction of 
these diseases. Homeland Security Presidential Directive (HSPD) 9 mandated the establishment of a National 
Veterinary Stockpile (NVS), a national repository that can deploy within 24 hours “sufficient amounts of animal 
vaccine, antiviral, or therapeutic products to appropriately respond to the most damaging animal diseases affecting 
human health and the economy” [12]. 
 
Table 5. USDA-APHIS-Veterinary Services Center for Veterinary Biologics active biotechnology products. 
 
Non-replicating recombinant antigen(s)-vaccine: 
Feline Leukemia Vaccine, Killed Virus 
Avian Influenza Vaccine, H5N3 Subtype, Killed Virus 
Porcine Circovirus Vaccine, Type 1 -Type 2 Chimera, Killed Virus 
Porcine Circovirus Vaccine, Type 2, Killed Baculovirus Vector 
Escherichia Coli Bacterin-Toxoid 
Borrelia Burgdorferi Bacterial Extract 
Feline Leukemia Virus Antigen 
 
Nucleic acid-mediated (not synthetic)-vaccine: 
West Nile Virus Vaccine, DNA 
Canine Melanoma Vaccine, DNA 
 
Live gene deleted: 
Escherichia Coli Vaccine, Live Culture 
Salmonella Dublin Vaccine, Live Culture 
Pseudorabies Vaccine, Modified Live Virus 
Salmonella Typhimurium Vaccine, Live Culture 
 
Live vectored: 
Marek's Disease Vaccine, Serotypes 1 & 3, Live Herpesvirus Chimera 
Avian Influenza-Fowl Pox Vaccine, H5 Subtype, Live Fowl Pox Vector 
Distemper Vaccine, Live Canarypox Vector 
Equine Influenza Vaccine, Live Canarypox Vector 
Canine Distemper-Adenovirus Type 2-Parvovirus Vaccine, Modified Live Virus, Canarypox Vector 
Canine Distemper-Adenovirus Type 2-Parainfluenza-Parvovirus Vaccine, Modified Live Virus, Canarypox Vector 
Rabies Vaccine, Live Canarypox Vector 
West Nile Virus Vaccine, Live Canarypox Vector 
Feline Leukemia Vaccine, Live Canarypox Vector 
Rabies Vaccine, Live Vaccinia Vector 
Newcastle Disease-Fowl Pox Vaccine, Live Fowl Pox Vector 
Fowl Pox-Mycoplasma Gallisepticum Vaccine, Live Fowl Pox Vector 
Fowl Pox-Laryngotracheitis Vaccine, Live Fowl Pox Vector 
Bursal Disease-Marek's Disease Vaccine, Serotype 3, Live Marek's Disease Vector 
Marek's Disease-Newcastle Disease Vaccine, Serotype 3, Live Marek's Disease Vector 
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The NVS advisory committee has identified the 17 highest priority foreign animal diseases for which vaccines, 
diagnostics and/or other countermeasures are needed (Table 6). The research and development needs for these 
countermeasures differ. There are significant challenges associated with meeting the licensing requirements 
mandated in Title 9 of the Code of Federal Regulations for biologics for these foreign animal diseases [13]. 
However, through collaborative efforts of the Department of Homeland Security, the USDA Center for Veterinary 
Biologics, and the biologics industry, significant progress is being made in licensing biologics to meet the mandate 
of HSPD 9. 
6. Challenges 
Much progress has been made in vaccine development in recent years; however, significant challenges remain. 
Animal and human infectious disease experts need to work together to prepare for new and emerging diseases. 
Veterinary vaccines must be pure, safe, potent and effective and they must be economical or they won’t be widely 
used. Proper standards and production controls in the manufacture of veterinary vaccines are essential for ensuring 
quality products for animal disease control. The regulatory process for evaluation of vaccines must ensure adequate 
evaluation of biologicals but be efficient for both the regulatory agencies and the biologics manufacturers. Keeping 
the costs of animal vaccines low will encourage more use of vaccines and less use of antibiotics. It will also enable 
the use of food safety vaccines that do not have an economic advantage for the producer or health advantage to the 
animal, but have important public health benefits. 
 
Table 6. Damaging animal diseases in priority order for inclusion of countermeasures into the National 
Veterinary Stockpile [10]. 
 
Agroterror Agent Animal Industries Affected Public Health Threat? 
1 Highly pathogenic avian influenza Poultry   Yes, may be lethal 
2 Foot-and-mouth disease Cattle, swine, sheep, and other cloven-hoofed livestock No 
3 Rift Valley fever Cattle, sheep Yes, may be lethal 
4 Exotic Newcastle disease Poultry  Yes, minor effects 
5 Nipah and Hendra viruses Swine (Nipah), horses (Hendra) Yes, may be lethal 
6 Classical swine fever  Swine No 
7 African swine fever Swine  No 
8 Bovine spongiform encephalopathy agent Cattle Suspected 
9 Rinderpest   Cattle, sheep No 
10 Japanese encephalitis Swine, equine Yes, may be lethal 
11 African horse sickness Equine No 
12 Venezuelan equine encephalitis Equine Yes, may be lethal 
13 Contagious bovine pleuropneumonia Cattle No 
14 Ehrlichia ruminantium (heartwater) Cattle, sheep, goats No 
15 Eastern equine encephalitis   Equine Yes, may be lethal 
16 Coxiella burnetii   Cattle, sheep, goats Yes, may be lethal 
17 Akabane   Cattle, sheep, goats No 
 
7. Conclusion 
The fact that so many people depend on livestock and poultry for their livelihoods and as a source of food limits 
policy options, complicates local and global trade decisions, and raises political sensitivities. It is inevitable that the 
world will continue to experience the emergence of new human and animal diseases in the coming decades. This 
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challenge mandates the need for the medical, veterinary, and public health communities to work together locally and 
internationally. Veterinary vaccines will continue to be an important tool to protect human health, animal health, 
food safety, and food security and must be accessible and economical. 
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